Onegene Biotechnology
Seongnam
About Onegene Biotechnology
Onegene Biotechnology is a biotechnology company that develops highly potent tri- or intraspecific protein-based drugs. It allows an unlimited combination of different types of molecules, such as Fab fragment, scFv, sdAb, peptide, cytokines, agonist/antagonist, or enzymes. The unprecedented design flexibility with optimized physical properties opens new design space for multispecific protein drugs with CMC feasibility.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $12.7M
- Last round: Series Unknown (May 2022)
- Website: onegenebt.com
- Phone: 031-8014-2842
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/onegene-biotechnology-36189 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.